About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Report Type
Organization
Disposition
Year
Month
Found 63825 record(s)
Req # A-2019-001177
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 19-109786-731.Organization: Health Canada
February 2020
Req # A-2019-001186
Adverse Reaction Report (AER). Report numbers: 000726733, 000727471, 000727145, 000727447, 000727461, E2B_02613557, E2B_02613574, E2B_02615695, E2B_02618617, E2B_02633454, E2B_02633494, E2B_02635778, E2B_02640180.Organization: Health Canada
February 2020
Req # A-2019-001252
Adverse Reaction Report (AER) for Feiba. Report numbers: 000725697, 000725702, 000725728, E2B_02473499, E2B_02570453.Organization: Health Canada
February 2020
Req # A-2019-001306
Adverse Reaction Report (AER). Report number: E2B_02401944.Organization: Health Canada
February 2020
Req # A-2019-001307
Adverse Reaction Report (AER). Report numbers: E2B_01976995, 000717699, E2B_02067407, E2B_02067408, E2B_01396150 E2B_02417864, 000717663, 000717695, E2B_01395492, E2B_02203139, 000722033, E2B_01977022.Organization: Health Canada
February 2020
Req # A-2019-001311
Adverse Reaction Report (AER) for Lisdexamfetamine dimesylate. Report numbers: E2B_02571533, E2B_02569168, E2B_ 02571544, E2B_ 02613386.Organization: Health Canada
February 2020
Req # A-2019-001312
Adverse Reaction Report (AER) for Mezavant / Mesalazine. Report numbers: E2B_02180506, E2B_02173182, E2B_02173617, E2B_02174032, E2B_02180506.Organization: Health Canada
February 2020
Req # A-2019-001313
Adverse Reaction Report (AER) for Mezavant / Mesalazine. Report numbers: E2B_02131519, 000718374, 000718252, E2B_02133821.Organization: Health Canada
February 2020
Req # A-2019-001314
Adverse Reaction Report (AER) for Vyvanse. Report numbers: E2B_02572800, E2B_02599805, E2B_02608582, E2B_02558019, E2B_02563899.Organization: Health Canada
February 2020
Req # A-2019-001429
Adverse Reaction Report (AER). Report number: E2B_02458664.Organization: Health Canada
February 2020